EUVIMEDEUVIMED entdecken
Crossref

A chance for Rituximab in Primary Biliary Cholangitis–Autoimmune Hepatitis Overlap Syndrome.

J Pereira Martinez, A Ruiz Sánchez, I Herrería Fernández, JM Sousa Martín

Revista Andaluza de Patología Digestiva · 11.03.2026 · 49 (1) · 29-31

DOI: 10.37352/2026491.5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista Andaluza de Patología Digestiva, online erschienen am 11.03.2026. Verfasst von J Pereira Martinez und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autoimmune hepatitis (AIH) and primary biliary cholangitis (PBC) may coexist as an overlap syndrome, which can be challenging to diagnose and manage. In this case report, we describe a patient with AIH–PBC overlap syndrome refractory to conventional immunosuppressive therapy and with steroid-dependent disease. Rituximab was administered as rescue therapy, achieving biochemical normalization. This case supports the potential role of rituximab as a therapeutic option in patients refractory to standard immunosuppressive treatments.

Zitieren

APA

Martinez, J. P., Sánchez, A. R., Fernández, I. H., & Martín, J. S. (2026). A chance for Rituximab in Primary Biliary Cholangitis–Autoimmune Hepatitis Overlap Syndrome. Revista Andaluza de Patología Digestiva, 49(1), 29-31. https://doi.org/10.37352/2026491.5

Vancouver

Martinez JP, Sánchez AR, Fernández IH, Martín JS. A chance for Rituximab in Primary Biliary Cholangitis–Autoimmune Hepatitis Overlap Syndrome. Revista Andaluza de Patología Digestiva. 2026;49(1):29-31. doi:10.37352/2026491.5

BibTeX
@article{Martinez2026,
  author = {Martinez, J Pereira and Sánchez, A Ruiz and Fernández, I Herrería and Martín, JM Sousa},
  title = {A chance for Rituximab in Primary Biliary Cholangitis–Autoimmune Hepatitis Overlap Syndrome},
  journal = {Revista Andaluza de Patología Digestiva},
  year = {2026},
  volume = {49},
  number = {1},
  pages = {29--31},
  doi = {10.37352/2026491.5}
}
Kostenlos starten →